Evidence map›Paper›PMID 35806282›Full record

ArticleInternational journal of molecular sciences2022

Synthesis of Antibacterial Hybrid Hydroxyapatite/Collagen/Polysaccharide Bioactive Membranes and Their Effect on Osteoblast Culture.

Lucas Fabrício Bahia Nogueira, Marcos Antônio Eufrásio Cruz, Guilherme José Aguilar, Delia Rita Tapia-Blácido, Márcia Eliana da Silva Ferreira, Bianca Chieregato Maniglia, Massimo Bottini, Pietro Ciancaglini, Ana Paula Ramos

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Hydroxyapatite-cellulose composites: properties, fabrication methods, and applications.Journal of materials science. Materials in medicine · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Lucas Fabrício Bahia NogueiraDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil.
Marcos Antônio Eufrásio CruzDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil.
Guilherme José AguilarDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil.ORCID 0000-0001-7236-2682
Delia Rita Tapia-BlácidoDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil.ORCID 0000-0002-8447-0311
Márcia Eliana da Silva FerreiraDepartamento de Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-900, Brazil.ORCID 0000-0001-8143-9821
Bianca Chieregato ManigliaDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil.ORCID 0000-0003-4174-5474
Massimo BottiniDepartment of Experimental Medicine, University of Rome Tor Vergata, 00133 Rome, Italy.ORCID 0000-0001-9237-8972
Pietro CiancagliniDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil.ORCID 0000-0002-2785-1345
Ana Paula RamosDepartamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto-Universidade de São Paulo, Ribeirão Preto 14040-901, Brazil.ORCID 0000-0001-6200-8989
Universidade de Ribeirão Preto · BRUniversity of Rome Tor Vergata · ITUniversidade de São Paulo · BR

Funding

São Paulo Research Foundation 16/25955-1São Paulo Research Foundation 19/25054-2São Paulo Research Foundation 20/08727-0São Paulo Research Foundation 2018/25871-8São Paulo Research Foundation 21/05947-2
6 · The paper itself

Abstract

Inspired by the composition and confined environment provided by collagen fibrils during bone formation, this study aimed to compare two different strategies to synthesize bioactive hybrid membranes and to assess the role the organic matrix plays as physical confinement during mineral phase deposition. The hybrid membranes were prepared by (1) incorporating calcium phosphate in a biopolymeric membrane for in situ hydroxyapatite (HAp) precipitation in the interstices of the biopolymeric membrane as a confined environment (Methodology 1) or (2) adding synthetic HAp nanoparticles (SHAp) to the freshly prepared biopolymeric membrane (Methodology 2). The biopolymeric membranes were based on hydrolyzed collagen (HC) and chitosan (Cht) or κ-carrageenan (κ-carr). The hybrid membranes presented homogeneous and continuous dispersion of the mineral particles embedded in the biopolymeric membrane interstices and enhanced mechanical properties. The importance of the confined spaces in biomineralization was confirmed by controlled biomimetic HAp precipitation via Methodology 1. HAp precipitation after immersion in simulated body fluid attested that the hybrid membranes were bioactive. Hybrid membranes containing Cht were not toxic to the osteoblasts. Hybrid membranes added with silver nanoparticles (AgNPs) displayed antibacterial action against different clinically important pathogenic microorganisms. Overall, these results open simple and promising pathways to develop a new generation of bioactive hybrid membranes with controllable degradation rates and antimicrobial properties.

Indexed as

ChitosanMetal NanoparticlesAnti-Bacterial AgentsCollagenDurapatiteOsteoblastsSilverAnti-Bacterial AgentsChitosanCollagenDurapatiteSilverbiomineralizationchitosancollagenhybrid membraneshydroxyapatite

Identifiers

PMID35806282
PMCPMC9267025
OpenAlexW4283750028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.